AR107663A1 - PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-HODGKINIAN LYMPHOMA (NHL) AND OTHER TYPES OF CANCER - Google Patents
PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-HODGKINIAN LYMPHOMA (NHL) AND OTHER TYPES OF CANCERInfo
- Publication number
- AR107663A1 AR107663A1 ARP170100409A ARP170100409A AR107663A1 AR 107663 A1 AR107663 A1 AR 107663A1 AR P170100409 A ARP170100409 A AR P170100409A AR P170100409 A ARP170100409 A AR P170100409A AR 107663 A1 AR107663 A1 AR 107663A1
- Authority
- AR
- Argentina
- Prior art keywords
- peptides
- seq
- peptide
- cancer
- hodgkinian
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente solicitud se refiere a péptidos, proteínas, ácidos nucleicos y células destinados a la utilización en métodos inmunoterapéuticos. En particular, la presente solicitud se refiere a la inmunoterapia contra el cáncer. Reivindicación 1: Péptido que comprende una secuencia de aminoácidos seleccionada entre el grupo consistente en la SEQ ID Nº 1 a la SEQ ID Nº 311, y secuencias variantes de las mismas que son como mínimo homólogas en un 88% a las SEQ ID Nº 1 a la SEQ ID Nº 311, y en que dicha variante se une a una o varias moléculas del complejo mayor de histocompatibilidad (MHC) y/o induce la reacción cruzada de linfocitos T con dicho péptido variante; y una sal farmacéuticamente aceptable del mismo, en que dicho péptido no es un polipéptido entero.The present application relates to peptides, proteins, nucleic acids and cells intended for use in immunotherapeutic methods. In particular, the present application relates to cancer immunotherapy. Claim 1: Peptide comprising an amino acid sequence selected from the group consisting of SEQ ID No. 1 to SEQ ID No. 311, and variant sequences thereof that are at least 88% homologous to SEQ ID No. 1 to SEQ ID No. 311, and in which said variant binds to one or several molecules of the major histocompatibility complex (MHC) and / or induces the cross-reaction of T lymphocytes with said variant peptide; and a pharmaceutically acceptable salt thereof, wherein said peptide is not a whole polypeptide.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662297495P | 2016-02-19 | 2016-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR107663A1 true AR107663A1 (en) | 2018-05-23 |
Family
ID=62596942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170100409A AR107663A1 (en) | 2016-02-19 | 2017-02-17 | PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-HODGKINIAN LYMPHOMA (NHL) AND OTHER TYPES OF CANCER |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR107663A1 (en) |
| EA (1) | EA202190465A3 (en) |
-
2017
- 2017-02-17 EA EA202190465A patent/EA202190465A3/en unknown
- 2017-02-17 AR ARP170100409A patent/AR107663A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA202190465A2 (en) | 2021-06-30 |
| EA202190465A3 (en) | 2022-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20230321A1 (en) | NEW PEPTIDES AND NEW PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER TYPES OF CANCER | |
| CL2018000124A1 (en) | New peptides and new combinations of peptides for use in immunotherapy against epithelial ovarian cancer and other types of cancer | |
| PE20181316A1 (en) | NEW PEPTIDES AND PEPTIDE COMBINATION FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TYPES OF CANCER | |
| PE20171515A1 (en) | NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREAS CANCER AND OTHER TYPES OF CANCER | |
| PE20210376A1 (en) | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONIC ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCER | |
| PE20191248A1 (en) | NEW PEPTIDES AND NEW PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER TYPES OF CANCER | |
| PE20180487A1 (en) | NEW PEPTIDES AND NEW COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA AND OTHER TYPES OF CANCER | |
| PE20181490A1 (en) | TREATMENTS AGAINST CANCER OF THE UTERUS | |
| AR127116A2 (en) | NOVEL PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | |
| PE20181897A1 (en) | IMMUNOTHERAPY AGAINST MELANOMA AND OTHER TYPES OF CANCER | |
| AR122964A2 (en) | PEPTIDES USEFUL IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER TYPES OF CANCER | |
| PE20181517A1 (en) | NEW PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCERS | |
| PE20180253A1 (en) | NEW PEPTIDES AND NEW COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS TO CREATE SUPPORTS FOR USE AGAINST PANCREAS CANCER AND OTHER TYPES OF CANCER | |
| PE20180505A1 (en) | PEPTIDES AND COMBINATION OF PEPTIDES AND NOVEL SCAFFOLDINGS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS | |
| PE20191711A1 (en) | PEPTIDES AND COMBINATIONS OF THE SAME FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TYPES OF CANCER | |
| AR106920A1 (en) | PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA (LLC) AND OTHER TYPES OF CANCER | |
| RU2020113032A (en) | NEW PEPTIDES AND PEPTID COMBINATIONS FOR USE IN LUNG CANCER IMMUNOTHERAPY, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC) AND OTHER CANCER SPECIES | |
| EP3712165A3 (en) | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| PE20191617A1 (en) | PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST LEUKEMIA AND OTHER TYPES OF CANCER | |
| CL2019003427A1 (en) | New peptides (seq id n ° 180), peptide combinations and carriers for use in the immunotherapeutic treatment of various types of cancer. (divisional request 201800545) | |
| PE20230343A1 (en) | PEPTIDES THAT STIMULATE ANTI-TUMORAL IMMUNE RESPONSES | |
| AR100824A1 (en) | IMMUNOGENIC POLYPROTEIN COMPLEX OF M. HYOPNEUMONIAE, SYNTHETIC GEN CODIFYING OF THE IMMUNOGENIC PROLIPROTEIN COMPLEX OF M. HYOPNEUMONIAE, ANTIGENIC COMPOSITION, PROCESS OF OBTAINING A COMPLEX COMPLETION COMPLEX IN A BASE HYDRAULIC COMPLEX. IMMUNOGENIC OF M. HYOPNEUMONIAE | |
| AR107768A1 (en) | PEPTIDES, COMBINATIONS OF PEPTIDES AND CELLS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER TYPES OF CANCER | |
| AR107663A1 (en) | PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-HODGKINIAN LYMPHOMA (NHL) AND OTHER TYPES OF CANCER | |
| PE20181896A1 (en) | NEW PEPTIDES AND NEW PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST WATER LEUKEMIA MYELOID (AML) AND OTHER TYPES OF CANCER |